Description
An N-nitroso-aminoglucose derivative which is used to produce animal models of diabetes [1]. Alkylates DNA [2]. Inhibits pancreatic β-cell O-Glc-NAc selective N-acetyl-β-D-glucosaminidase [3]. Selectively induces death of β-cells which mechanistically is independent of N-acetyl-β-D-glucosaminidase inhibition [4]. Is not a spontaneous NO donor [5].
References:
1) Szkudelski et al. (2001), The mechanism of alloxan and streptozotocin action in B cells of the rat pancreas.; Physiol. Res., 50 537
2) Bennett & Pegg (1981), Alkylation of DNA in rat tissues following administration of streptozotocin; Cancer Res., 41 2786
3) Konrad et al. (2001), The potential mechanism of the diabetogenic action of streptozotocin inhibition of pancreatic beta-cell O-GlcNAc-selective N-acetyl-beta-D-glucosaminidase; Biochem. J., 356 Pt 1 31
4) Gao et al. (2000), Streptozotocin-induced beta-cell death is independent of its inhibition of O-GlcNAcase in pancreatic Min6 cells; Arch. Biochem. Biophys., 383 296
5) Kroncke & Kolb-Bachofen (1996), Streptozotocin is not a spontaneous NO donor.; Free Radic. Res., 24 77
No product image on file for this SKU yet.
Related products
- 17-AAG
- 2-NBD-Glucose
- A83-01
- ABT-263
- ABT-737
- Actinomycin D
- Amlexanox
- Auraptene
- AZD 6244
- BI-2536
- Bortezomib
- BRM014
For research use only. Not for diagnostic or clinical use.